Recursion Pharmaceuticals (RXRX) Receivables - Net (2020 - 2022)
Recursion Pharmaceuticals (RXRX) reported Receivables - Net of $21000.0 for Q2 2022, down 57.14% on a YoY basis from $49000.0 in Q2 2021, and down 38.24% quarter-over-quarter from $34000.0 in Q1 2022.
Recursion Pharmaceuticals (RXRX) Receivables - Net (2020 - 2022) Analysis & Trends
Recursion Pharmaceuticals has reported Receivables - Net for 3 years, with the latest figure at $21000.0 in Q2 2022.
- For the quarter ending Q2 2022, Receivables - Net fell 57.14% year-over-year to $21000.0; the trailing twelve-month figure through Jun 2022 stood at $21000.0 (down 57.14% YoY), and the FY2021 full-year result was $34000.0, down 78.21% from the prior year.
- Receivables - Net for Q2 2022 stood at $21000.0, down from $34000.0 in the prior quarter.
- The five-year high for Receivables - Net was $156000.0 in Q4 2020, with the low at $21000.0 in Q2 2022.
- Historically, Receivables - Net has averaged $55714.3 across 3 years, with a median of $34000.0 in 2021.
- Annual changes were most pronounced in 2021 — Receivables - Net plunged 78.21% — and 2022, when it sank 45.16%.
- Recursion Pharmaceuticals' Receivables - Net stood at $156000.0 in 2020, then sank by 78.21% to $34000.0 in 2021, then slumped by 38.24% to $21000.0 in 2022.
- The last three Receivables - Net figures came in at $21000.0 (Q2 2022), $34000.0 (Q1 2022), and $34000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 21,000.00 |
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 49,000.00 |
| Jun 30, 2021 | 49,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Dec 31, 2020 | 156,000.00 |
| Dec 31, 2020 | 156,000.00 |